--a Zoom call scheduled with WinSanTor CEO Stanley Kim for this Thursday afternoon; I'll see what he says and report back.

During that webinar, he does make a big push for increased advocacy as regards neuropathy, and getting people to even recognize it as an entity, which has been one of my major initiatives over nearly twenty years of activism at this point. We'll see what ideas we can cross pollinate, and how serious the company might be beyond getting the drug approved.